// App-Quantinova.ai

TCTAP A-071 : One-year Outcomes Following Implantation of the Resolute Zotarolimus-eluting Stent in an Asian, Dual Vessel Population: RESOLUTE Asia

Researchers

Presenter

  • Robaayah Zambahari

Principal Investigators

  • Michael Lee

  • Shirish Hiremath

Medical Centers

  • Ruby Hall Clinic, Pune, India

  • Queen Elizebeth Hospital, Hong Kong, Hong Kong

  • National Heart Institute, Kuala Lumpur, Malaysia

Locations

  • Malaysia

  • India

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Coronary Artery Disease

  • Myocardial infarction

  • Venous thrombosis

  • Diabetes

Biomarkers

  • Acetyl-CoA carboxylase

Drug/Treatment

  • ZoMaxx

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved